Laura Calabresi

Title: Laura Calabresi: Innovator in Kidney Disease Therapy

Introduction

Laura Calabresi is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of medical therapies, particularly in the treatment of kidney diseases. With a total of two patents to her name, her work is paving the way for innovative solutions in healthcare.

Latest Patents

Calabresi's latest patents focus on the use of CER-001 therapy for treating kidney disease. This therapy involves a negatively charged lipoprotein complex that comprises recombinant human apolipoprotein A-I (ApoA-I), sphingomyelin (SM), and 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG). The patent details methods for treating subjects with kidney diseases, particularly those associated with a lecithin cholesterol acyl transferase (LCAT) deficiency. This innovative approach aims to improve the quality of life for patients suffering from these conditions.

Career Highlights

Laura Calabresi is currently associated with Abionyx Pharma SA, where she continues to develop groundbreaking therapies. Her dedication to research and innovation has positioned her as a key figure in the pharmaceutical industry.

Collaborations

Some of her notable coworkers include Jean-Louis Henri Dasseux and Cyrille Tupin, who contribute to her research efforts and the advancement of her projects.

Conclusion

Laura Calabresi's work in developing therapies for kidney disease exemplifies the impact of innovation in healthcare. Her patents and collaborations highlight her commitment to improving patient outcomes through scientific advancements.